193 related articles for article (PubMed ID: 9208141)
1. Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors.
Hall DA; Strange PG
Br J Pharmacol; 1997 Jun; 121(4):731-6. PubMed ID: 9208141
[TBL] [Abstract][Full Text] [Related]
2. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P
Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773
[TBL] [Abstract][Full Text] [Related]
3. Inverse agonist properties of atypical antipsychotic drugs.
Akam E; Strange PG
Biochem Pharmacol; 2004 Jun; 67(11):2039-45. PubMed ID: 15135301
[TBL] [Abstract][Full Text] [Related]
4. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
[TBL] [Abstract][Full Text] [Related]
5. The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells.
Zhang LJ; Lachowicz JE; Sibley DR
Mol Pharmacol; 1994 May; 45(5):878-89. PubMed ID: 7910658
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.
Jordan S; Johnson JL; Regardie K; Chen R; Koprivica V; Tadori Y; Kambayashi J; Kitagawa H; Kikuchi T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):348-56. PubMed ID: 17070976
[TBL] [Abstract][Full Text] [Related]
7. Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic.
Tadori Y; Miwa T; Tottori K; Burris KD; Stark A; Mori T; Kikuchi T
Eur J Pharmacol; 2005 May; 515(1-3):10-9. PubMed ID: 15894311
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2L receptors stimulate Na+/K(+)-ATPase activity in murine LTK- cells.
Yamaguchi I; Walk SF; Jose PA; Felder RA
Mol Pharmacol; 1996 Feb; 49(2):373-8. PubMed ID: 8632772
[TBL] [Abstract][Full Text] [Related]
9. D2 dopamine receptor-mediated antiproliferation in a small cell lung cancer cell line, NCI-H69.
Senogles SE
Anticancer Drugs; 2007 Aug; 18(7):801-7. PubMed ID: 17581302
[TBL] [Abstract][Full Text] [Related]
10. D2 dopamine receptor stimulation of mitogenesis in transfected Chinese hamster ovary cells: relationship to dopamine stimulation of tyrosine phosphorylations.
Lajiness ME; Chio CL; Huff RM
J Pharmacol Exp Ther; 1993 Dec; 267(3):1573-81. PubMed ID: 7903393
[TBL] [Abstract][Full Text] [Related]
11. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
[TBL] [Abstract][Full Text] [Related]
12. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
13. Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells.
Boundy VA; Pacheco MA; Guan W; Molinoff PB
Mol Pharmacol; 1995 Nov; 48(5):956-64. PubMed ID: 7476927
[TBL] [Abstract][Full Text] [Related]
14. Paradoxical regulation of dopamine receptors in transfected 293 cells.
Filtz TM; Artymyshyn RP; Guan W; Molinoff PB
Mol Pharmacol; 1993 Aug; 44(2):371-9. PubMed ID: 8102783
[TBL] [Abstract][Full Text] [Related]
15. Constitutive coupling of a chimeric dopamine D2/alpha 1B receptor to the phospholipase C pathway: inverse agonism to silent antagonism by neuroleptic drugs.
Wurch T; Boutet-Robinet EA; Palmier C; Colpaert FC; Pauwels PJ
J Pharmacol Exp Ther; 2003 Jan; 304(1):380-90. PubMed ID: 12490615
[TBL] [Abstract][Full Text] [Related]
16. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
17. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
Newman-Tancredi A; Cussac D; Audinot V; Pasteau V; Gavaudan S; Millan MJ
Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the mechanism of agonist and inverse agonist action at D2 dopamine receptors.
Roberts DJ; Lin H; Strange PG
Biochem Pharmacol; 2004 May; 67(9):1657-65. PubMed ID: 15081865
[TBL] [Abstract][Full Text] [Related]
19. Real-time analysis of dopamine: antagonist interactions at recombinant human D2long receptor upon modulation of its activation state.
Pauwels PJ; Tardif S; Wurch T; Colpaert FC
Br J Pharmacol; 2001 Sep; 134(1):88-97. PubMed ID: 11522600
[TBL] [Abstract][Full Text] [Related]
20. Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.
Chio CL; Lajiness ME; Huff RM
Mol Pharmacol; 1994 Jan; 45(1):51-60. PubMed ID: 8302280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
